Literature DB >> 22935656

Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil.

Mecneide Mendes Lins1, Melania Amorim, Paulo Vilela, Michelle Viana, Raul C Ribeiro, Arli Pedrosa, Norma Lucena-Silva, Scott C Howard, Francisco Pedrosa.   

Abstract

The objectives of this study were to describe the interval between symptom onset and diagnosis of acute leukemia, to assess risk factors for delayed diagnosis, and its effect on early morbid-mortality and event-free survival (EFS). Records of children aged 1 month to 18 years diagnosed with acute leukemia were reviewed for clinical, demographic, and health care provider factors, and for time to diagnosis. Of 288 patients diagnosed, 55% had a delay in diagnosis. The median time to diagnosis was 31 days. There were significant associations between the diagnostic delay and the distance from the tertiary care hospital (P=0.04), initial consultation in an outpatient clinic (P=0.04), presenting symptoms of bone/joint pain (P=0.04), family with more than 3 children (P=0.02), birth order of third or greater (P=0.009), paternal age <30 years (P=0.03), and paternal education <8 years (P=0.008). There was no association between delayed diagnosis and early morbid-mortality or EFS at 5 years. Initial consultation in an outpatient setting, presenting symptoms of bone/joint pain, and birth order of third or greater remained statistically significant in multivariate analyses, but the delay did not have an impact on early morbid-mortality or EFS. Education of primary care providers in atypical presentations of acute leukemia may decrease the diagnostic delay.

Entities:  

Mesh:

Year:  2012        PMID: 22935656     DOI: 10.1097/MPH.0b013e3182580bea

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Childhood Cancer Survival, 2006-2012 Cohorts of Mexican Institute of Social Security Beneficiaries at the Central-South Region of Mexico.

Authors:  Angélica Castro-Ríos; Silvia Martínez-Valverde
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

Review 2.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

3.  Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional survey.

Authors:  Geoffrey C Buckle; Jennifer Pfau Collins; Peter Odada Sumba; Beccy Nakalema; Dorine Omenah; Kristine Stiffler; Corey Casper; Juliana A Otieno; Jackson Orem; Ann M Moormann
Journal:  Infect Agent Cancer       Date:  2013-09-30       Impact factor: 2.965

4.  Pediatric Cancer Recognition Training in Botswana.

Authors:  Jeremy S Slone; Elise Ishigami; Parth S Mehta
Journal:  Glob Pediatr Health       Date:  2016-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.